Company: AVCRF
Filing Date: 2025-06-16
Form Type: 20-F
Source: 0001641172-25-015266
Chunk: 74

Company: Avricore Health Inc.
Filing Date: 2025-06-16
Form: 20-F
Item: Item 19
Chunk 74
---
 such indication of impairment exists, the Company makes an estimate of its recoverable amount. The recoverable amount is the higher
of fair value less costs of disposition and value in use. Where the carrying amount of a cash generating unit exceeds its recoverable
amount, the cash generating unit is considered impaired and is written down to its recoverable amount. In assessing the value in use,
the estimated future cash flows are adjusted for the risks specific to the cash generating unit and are discounted to their present value
with a discount rate that reflects the current market indicators. The recoverable amount of intangible assets with an indefinite useful
life, intangible assets not available for use, or goodwill acquired in a business combination are measured annually whether or not there
are any indications that impairment exists.

Where
an impairment loss subsequently reverses, the carrying amount of the cash generating unit is increased to the revised estimate of its
recoverable amount, to the extent that the increased carrying amount does not exceed the carrying amount that would have been determined
had no impairment loss been recognized for the cash generating unit in prior years. A reversal of an impairment loss is recognized as
income immediately.

  Significant                         
  accounting estimates and judgments  
 ──────────────────────────────────────

Estimates

Significant
estimates used in applying accounting policies that have the most significant effect on the amounts recognized in the financial statements
are as follows:

Share-based
payments

The
Company grants share-based awards to certain directors, officers, employees, consultants and other eligible persons. For equity-settled
awards, the fair value is charged to the statement of operations and comprehensive income (loss) and credited to the reserves over the
vesting period using the graded vesting method, after adjusting for the estimated number of awards that are expected to vest.

Avricore
Health Inc.

Notes
to the Consolidated Financial Statements

For
the years ended December 31, 2024, 2023 and 2022

(Expressed
in Canadian Dollars)

  SUMMARY                                      
  OF MATERIAL ACCOUNTING POLICIES (continued)  
 ───────────────────────────────────────────────

  Significant                                     
  accounting estimates and judgments (continued)  
 ──────────────────────────────────────────────────

The
fair value of equity-settled awards is determined at the date of the grant using the Black-Scholes option pricing model. For equity-settled
awards to non-employees, the fair value is measured at each vesting